These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9512957)

  • 1. Genotype distribution of hepatitis C virus infection in Greece: correlation with different risk factors and response to interferon therapy.
    Diamantis I; Vafiadis I; Voskaridou E; Dellatetsima J; Jäggi N; Gyr K; Battegay M
    Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):75-9. PubMed ID: 9512957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients.
    Adinolfi LE; Utili R; Andreana A; Tripodi MF; Rosario P; Mormone G; Ragone E; Pasquale G; Ruggiero G
    Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):299-304. PubMed ID: 10750650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
    Martinot-Peignoux M; Boyer N; Pouteau M; Castelnau C; Giuily N; Duchatelle V; Aupérin A; Degott C; Benhamou JP; Erlinger S; Marcellin P
    J Hepatol; 1998 Aug; 29(2):214-23. PubMed ID: 9722202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP.
    Martinot-Peignoux M; Roudot-Thoraval F; Mendel I; Coste J; Izopet J; Duverlie G; Payan C; Pawlotsky JM; Defer C; Bogard M; Gerolami V; Halfon P; Buisson Y; Fouqueray B; Loiseau P; Lamoril J; Lefrere JJ; Marcellin P
    J Viral Hepat; 1999 Nov; 6(6):435-43. PubMed ID: 10607261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hepatitis G virus coinfection on severity of hepatitis C: relationship to risk factors and response to interferon treatment.
    Lin R; Dutta U; Kaba S; Kench J; Crewe E; Coverdale S; Byth K; Liddle C; Farrell GC
    J Gastroenterol Hepatol; 1998 Aug; 13(8):773-80. PubMed ID: 9736169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of the relationship between hepatitis c virus (HCV) genotypes with HCV-RNA and alanine aminotransferase levels in chronic hepatitis c patients].
    Küçköztaş MF; Ozgünes N; Yazici S
    Mikrobiyol Bul; 2010 Jan; 44(1):111-5. PubMed ID: 20455406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypes of hepatitis C virus in relapsed and non-respondent patients and their response to anti-viral therapy in district Mardan, Khyber Pakhtunkhawa, Pakistan.
    Akhtar N; Bilal M; Rizwan M; Khan MA; Khan A
    Asian Pac J Cancer Prev; 2015; 16(3):1037-40. PubMed ID: 25735327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus genotyping in Greece: unexpected high prevalence of genotype 5a in a Greek island.
    Karatapanis S; Tsoplou P; Papastergiou V; Vasiageorgi A; Stampori M; Saitis I; Tsitsopoulos E; Lisgos P; Skorda L; Ketikoglou I; Goulis I
    J Med Virol; 2012 Feb; 84(2):223-8. PubMed ID: 22170541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison.
    Tong MJ; Blatt LM; McHutchison JG; Co RL; Conrad A
    Hepatology; 1997 Dec; 26(6):1640-5. PubMed ID: 9398010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.
    Mazzoran L; Grassi G; Giacca M; Gerini U; Baracetti S; Fanni-Canelles M; Zorat F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes.
    Behzadpour D; Ahmadi Vasmehjani A; Mousavi Nasab SD; Ahmadi NA; Baharlou R
    Pathog Glob Health; 2016; 110(7-8):310-315. PubMed ID: 27830997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT.
    Brouwer JT; Hansen BE; Niesters HG; Schalm SW
    J Hepatol; 1999 Feb; 30(2):192-8. PubMed ID: 10068095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.
    Soresi M; Tripi S; Franco V; Giannitrapani L; Alessandri A; Rappa F; Vuturo O; Montalto G
    Liver Int; 2006 Nov; 26(9):1119-25. PubMed ID: 17032413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy.
    Kumthip K; Chusri P; Pantip C; Thongsawat S; O'Brien A; Nelson KE; Maneekarn N
    J Med Virol; 2014 Aug; 86(8):1360-5. PubMed ID: 24777626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C: assessment of virological, biochemical and histological treatment response.
    Petrenkiene V; Gudinaviciene I; Jonaitis L; Kupcinskas L
    Medicina (Kaunas); 2004; 40(6):538-46. PubMed ID: 15208476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy of interferon alfa treatment in chronic hepatitis C in relation to the serum concentration of RNA-HCV and the viral genotype].
    Hermida M; Castro A; López S; Vega P; Pedreira J
    An Med Interna; 1997 Oct; 14(10):500-5. PubMed ID: 9424139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study.
    Bjøro K; Bell H; Myrvang B; Skaug K; Raknerud N; Sandvei P; Størseth S; Ritland S; Lund-Tønnesen S; Bucher A; Hellum KB
    Scand J Gastroenterol; 2002 Mar; 37(3):344-9. PubMed ID: 11916198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.